Refreshing results…
A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis
Download from doi.orgDihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia
Download from doi.orgAcute promyelocytic leukemia (APL) in very old patients: real-life behind protocols
UploadImpact of Comorbidities and Body Mass Index on the Outcome of Polycythemia Vera Patients
UploadSecond primary malignancy in myelofibrosis patients treated with ruxolitinib
UploadCOVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey
Download from www.nature.comMissing publications? Search for publications with a matching author name.